Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens. (Q36313603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

meningococcal vaccine

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sue Crengle

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

13

Diana Lennon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

Diana Martin

1 reference

8 January 2020

7

Philipp Oster

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

Jane O'Hallahan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

10

Ingeborg Aaberge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8

Ellen Ypma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Kumanan Rasanathan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Florina Chan Mow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Catherine Jackson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stewart Reid

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Joanna Stewart

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

26 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Vaccine Immunology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1393-1399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac

8 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Meningococcal surrogates of protection--serum bactericidal antibody activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Human immunity to the meningococcus. II. Development of natural immunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Human immunity to the meningococcus. I. The role of humoral antibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

The Norwegian meningococcal group B outer membrane vesicle vaccine: side effects in phase II trials

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2168176

The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic

22 September 2018

1 reference

12 December 2020

New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16???24 Months

1 reference

12 December 2020

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

12 December 2020

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

12 December 2020

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile

1 reference

12 December 2020

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease

1 reference

12 December 2020

Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials

1 reference

12 December 2020

Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control

1 reference

12 December 2020

Vaccine prevention of meningococcal disease: making slow progress

1 reference

12 December 2020

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

1 reference

12 December 2020

Identifiers

DOI

10.1128/CVI.00167-07

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898183%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

17898183

1 reference